@article{c320f4994eaa48ae83d5da2bd77bab76,
title = "Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre",
keywords = "PD-1 (PDCD1) inhibitors, Richter syndrome, chronic lymphocytic leukaemia, immune checkpoint inhibitors",
author = "Rogers, {Kerry A.} and Ying Huang and Emily Dotson and Jordan Lundberg and Andritsos, {Leslie A.} and Awan, {Farrukh T.} and Woyach, {Jennifer A.} and Byrd, {John C.}",
note = "Funding Information: K.A.R. receives research funding from Genentech. L.A.A. receives research funding from Sanofi. F.T.A. has consulted for AbbVie, Gilead Sciences and Janssen, and receives research funding from Pharmacyclics. J.A.W. received honoraria from Janssen, has consulted for Janssen, and receives research funding from MorphoSys, Karyopharm Therapeutics and AbbVie. J.C.B. receives research funding from Genentech, Acerta Pharma, Pharmacyclics, and Janssen. Y.H., E.D. and J.L. have no disclosures. Funding Information: The authors would like to thank the Ohio State University Division of Hematology for support of this project. They would also like to acknowledge their colleagues who provided the clinical care for the included patients.",
year = "2019",
month = apr,
doi = "10.1111/bjh.15508",
language = "English (US)",
volume = "185",
pages = "363--366",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",
}